I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Vosoritide for Selected Genetic Causes of Short Stature
hypothesizes that patients with selected genetic causes of short stature that interact with this pathway will benefit from treatment with vosoritide, a CNP analog, a selective NPR-B agonist which directly
saddan syndrome
shox deficiency
igf-i
cardiofaciocutaneous syndrome
regulatory region
- 62 views
- 10 May, 2021
- 1 location
A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia
Study 111-209 is a Phase 2 randomized, open-label clinical trial of BMN 111 in infants and young children with a diagnosis of Achondroplasia at a heightened risk of requiring cervicomedullary decompression surgery
- 28 views
- 27 Apr, 2022
- 2 locations